|Articles|November 1, 1999

November 1999
Volume 5
Issue 11

The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation

Author(s)Brenda R. Motheral, PhD, Rochelle Henderson, MPA

Download PDF: The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation

Articles in this issue

over 26 years ago

Article

Doctor, I'm Having a Heart Attack, What Should I Do?

over 26 years ago

Article

Attitudes Toward Managed Care and Cost Containment Among Primary Care Trainees at 3 Training Sites

over 26 years ago

Article

Satisfaction with Pregnancy and Newborn Care: Development and Results of a Survey in a Health Maintenance Organization

over 26 years ago

Article

The Cost of Medicaid-Covered Services Provided to Disabled Adults with Neurologic Disorders: Implications for Managed Care

over 26 years ago

Article

Estimates of Costs of Primary Care Physician Turnover

over 26 years ago

Article

Paying for HIV/AIDS Care at the Turn of the Century

over 26 years ago

Article

Developing a Managed Care Delivery System for People with HIV/AIDS

over 26 years ago

Article

Comprehensive HIV Services Under a Capitated Reimbursement System: AIDS Healthcare Foundation

over 26 years ago

Article

Developing a Managed Care Delivery System in New York State for Medicaid Recipients with HIV

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

The Effect of a Copay Increase on Pharmaceutical Utilization, Expenditures, and Treatment Continuation

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment

CMS Proposes Permanent Rules for Medicare Drug Price Negotiation

CKD Stage, Proteinuria Tied to Higher HCRU in IgAN

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology